NYSE:BSX - Boston Scientific Stock Price, Price Target & More

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Boston Scientific Co. (NYSE:BSX) announced its quarterly earnings results on Wednesday, April, 25th. The medical equipment provider reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.32 by $0.01. The medical equipment provider had revenue of $2.38 billion for the quarter, compared to the consensus estimate of $2.34 billion. Boston Scientific had a net margin of 1.21% and a return on equity of 25.10%. Boston Scientific's revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.29 EPS. View Boston Scientific's Earnings History.

Boston Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Boston Scientific.

Boston Scientific updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided EPS guidance of $1.37-1.41 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.37. The company issued revenue guidance of $9.75-9.90 billion (+5-7% organic), compared to the consensus revenue estimate of $9.75 billion.Boston Scientific also updated its Q2 guidance to $0.33-0.35 EPS.

22 Wall Street analysts have issued twelve-month price objectives for Boston Scientific's stock. Their forecasts range from $27.00 to $38.00. On average, they anticipate Boston Scientific's share price to reach $32.8182 in the next year. This suggests that the stock has a possible downside of 3.3%. View Analyst Ratings for Boston Scientific.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 3 hold ratings, 16 buy ratings and 3 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Boston Scientific saw a decline in short interest in the month of June. As of June 15th, there was short interest totalling 11,140,076 shares, a decline of 22.5% from the May 31st total of 14,367,253 shares. Based on an average daily volume of 13,883,441 shares, the short-interest ratio is presently 0.8 days. Approximately 0.8% of the shares of the company are short sold. View Boston Scientific's Current Options Chain.

Some companies that are related to Boston Scientific include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), FRESENIUS SE &/S (FSNUY), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN).

Media headlines about BSX stock have trended somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Boston Scientific earned a media sentiment score of 0.07 on Accern's scale. They also gave press coverage about the medical equipment provider an impact score of 45.68 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Boston Scientific's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Retirement Systems of Alabama (0.14%), Atalanta Sosnoff Capital LLC (0.09%), Gateway Investment Advisers LLC (0.06%), Bank of Montreal Can (0.06%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%) and Assenagon Asset Management S.A. (0.02%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, John E Sununu, Joseph Michael Fitzgerald, Keith D Dawkins, Kevin J Ballinger, Maulik Nanavaty, Michael F Mahoney, Michael P Phalen, Supratim Bose, Timothy A Pratt, Valley Gold Master Fund L Sun and Wendy Carruthers. View Institutional Ownership Trends for Boston Scientific.

BSX stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Retirement Systems of Alabama, Gateway Investment Advisers LLC, Assenagon Asset Management S.A., Xact Kapitalforvaltning AB, Private Trust Co. NA and Banced Corp. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Michael P Phalen, Supratim Bose, Timothy A Pratt and Wendy Carruthers. View Insider Buying and Selling for Boston Scientific.

BSX stock was purchased by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Atalanta Sosnoff Capital LLC, State of Alaska Department of Revenue, IFM Investors Pty Ltd, Fjarde AP Fonden Fourth Swedish National Pension Fund, DnB Asset Management AS, Atria Investments LLC and Catawba Capital Management VA. Company insiders that have bought Boston Scientific stock in the last two years include John E Sununu and Valley Gold Master Fund L Sun. View Insider Buying and Selling for Boston Scientific.

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BSX stock can currently be purchased for approximately $33.95.

Boston Scientific has a market capitalization of $46.02 billion and generates $9.05 billion in revenue each year. The medical equipment provider earns $105 million in net income (profit) each year or $1.26 on an earnings per share basis. Boston Scientific employs 29,000 workers across the globe.

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]